HOME >> MEDICINE >> NEWS
Zengen's new study reviews novel approach to control inflammation using melanocortin receptors

WOODLAND HILLS, Calif. (March 3, 2004) Zengen, Inc. announced today that its researchers have discovered that activation of melanocortin receptors (MCR) subtypes MC1R and MC3R could be a novel strategy to control inflammatory disorders.

The findings, "Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation," appear in the March 2004 issue of Pharmacological Reviews, a publication of the American Society for Pharmacology and Experimental Therapeutics (ASPET).

"MCR activation causes a collective reduction of the major molecules involved in the inflammatory process," said Anna Catania, M.D., professor of endocrinology, School of Internal Medicine, University of Milan and lead author of the study. "This discovery is significant because it shows that treatment with melanocortin peptides doesn't abolish the inflammatory response but instead modulates it. An advantage of melanocortins in the treatment of inflammation is that their influences are broad and are not restricted to a specific mediator or chemical pathway."

Recognition and cloning of five melanocortin receptors has greatly improved understanding of peptide-target cell interactions. Preclinical investigations indicate that activation of certain MCR subtypes, primarily MC1R and MC3R, could be useful in treatment of localized and systemic inflammatory disorders. These include: organ transplantation, chronic inflammatory diseases, acute inflammation, inflammation within the brain and neurogenerative disorders, peripheral neuropathies, systemic host reactions, ischemia and reperfusion injury and infections.

"The study results also indicate that certain melanocortin peptides have antimicrobial effects," said James Lipton, Ph.D., chief scientific officer and director of Zengen and study author. "Unlike corticosteroids, melanocortins do not reduce microbial killing activity, but enhance it. We are encouraged by these findings and will continue our res
'"/>


3-Mar-2004


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. UMaine study looks at infants and chronic nighttime crying
3. Chronic pain treatments more effective when taken together, new study shows
4. UNC study: Most N.C. family practitioners engage in unrecognized community service
5. New study in Nature demonstrates protection against cell death during heart attack
6. UCSF study offers insight into human circadian rhythms
7. International breast cancer prevention study launches in the United States and Canada
8. UW study shows blacks and Latinos are more satisfied with physicians of the same race
9. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
10. Advertising by academic medical centers may risk eroding public trust, says study
11. Fat may promote inflammation, new study suggests

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/12/2019)... ... 2019 , ... Remote Medical Technologies (RMT) will be a ... Annual Meeting being held in National Harbor, Maryland on March 18th to the ... RMT’s Mobile-Cart Solution . These solutions are high-performance HD telepathology systems ...
(Date:3/12/2019)... ... 12, 2019 , ... Caring Transitions is pleased to recognize Caring Transitions North ... owned by mother/daughter team Donna and Nicole Rea with the support of their team. ... Donna and Nicole of Caring Transitions of North Dallas Suburbs drove them to be ...
(Date:3/12/2019)... ... March 12, 2019 , ... When it comes to selecting ... to treat pain and diseases of joints, muscles, tendons and ligaments, “choose wisely,” ... the movie Indiana Jones. , “Some clinics and health centers have been built ...
(Date:3/12/2019)... , ... March 12, 2019 , ... A recent report ... facilities. Focusing on a series of Idaho case studies, the report argues that charter ... These arguments, while focused on Idaho in this particular report, have been made with ...
(Date:3/12/2019)... ... March 12, 2019 , ... The U.S. healthcare industry has ... each patient moving through different care settings. With a shared goal of providing ... ® today announced its support for broader discussions about the unique patient identifier ...
Breaking Medicine News(10 mins):
(Date:3/16/2019)... Hartford, CT (PRWEB) , ... March 16, 2019 , ... ... Ryaz Ansari are proud to announce that they are launching the JawFixers Implant Synergy ... March 27, 2019. This series is designed for implant clinicians to better understand the ...
(Date:3/15/2019)... , ... March 15, 2019 , ... Peter Saltonstall ... will be the keynote speaker at Keck Graduate Institute’s 18th annual commencement ceremony on ... CEO in 2008 after he served for more than 30 years as a senior ...
(Date:3/14/2019)... WARNER ROBINS, Ga. (PRWEB) , ... March 14, ... ... small minority-owned business enterprise (MBE) LOUi Consulting Group, Inc. (LCGI) its fourth consecutive ... DHA has awarded LCGI a $7M, 22-month contract to maintain the computer servers ...
Breaking Medicine Technology:
Cached News: